Olivera Bozickovic

Staff Engineer

Academic article

Show author(s) (2024). Clinicopathological and radiological stratification within FIGO 2018 stages improves risk-prediction in cervical cancer. Gynecologic Oncology. 110-117.

Show author(s) (2021). Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis. Communications Medicine. 1-14.

Show author(s) (2020). Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer. Gynecologic Oncology. 1-9.

Show author(s) (2018). A novel SRC-2-dependent regulation of epithelial-mesenchymal transition in breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology. 57-70.

Show author(s) (2015). The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells. PLOS ONE. 19 pages.
Show author(s) (2015). Metformin inhibits hepatocellular glucose, lipid and cholesterol biosynthetic pathways by transcriptionally suppressing steroid receptor coactivator 2 (SRC-2). Scientific Reports.
Show author(s) (2015). Cyclin C interacts with steroid receptor coactivator 2 and upregulates cell cycle genes in MCF-7 cells. BBA - Molecular Cell Research. 2383-2391.

Show author(s) (2013). cAMP response element-binding protein interacts with and stimulates the proteasomal degradation of the nuclear receptor coactivator GRIP1. Endocrinology. 1513-1527.

Doctoral dissertation

Show author(s) (2015). Regulation and function of steroid receptor coactivator 2 in hepatoma and breast cancer cells.

Poster

Show author(s) (2016). Repression of liver SRC-2 by metformin inhibits glucose, lipid and cholesterol biosynthesis.

Show author(s) (2014). Steroid receptor coactivators during short-term estrogen deprivation.

PhD, University of Bergen.

Master degree in Molecular biology, University of Bergen.

Diploma in Molecular biology, University of Zagreb.